Clinical Trials
76 trialsCharacterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
Penn State University
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
LUDICAS
Fundación GECP
SPACEWALK
Addario Lung Cancer Medical Institute
IMPROVE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer
Fudan University
PRIORITY
Institut Bergonié
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Pfizer
DELINOR
Pfizer
The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
Boehringer Ingelheim
Mini Invasive Endomicroscopy of the Pleura for Malignancies Diagnosis
University of Liege
Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma
Boehringer Ingelheim
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
Abramson Cancer Center at Penn Medicine
OCDNA
University of Minnesota
Alvopem® (Pemetrexed) Safety Assessment
NanoAlvand
ALK2016CPHG
Pfizer
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
Pfizer
Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.
Boehringer Ingelheim
DECIDE
Hackensack Meridian Health
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)
Pfizer
Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV
Fred Hutchinson Cancer Center
Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients
Pfizer
Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy
Boehringer Ingelheim
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico
UpSwinG
Boehringer Ingelheim
Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
Pfizer
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
AIDS Malignancy Consortium
Use of a New Stapling Device in General Thoracic Surgery
Lexington Medical Inc.
NAVABLATE
Medtronic - MITG
Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings
Boehringer Ingelheim
A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
Boehringer Ingelheim
BEPACT- Lung
MSD Belgium BVBA
Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
University of Chicago
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
Wissenschaftliches Institut Bethanien e.V
GIOTRIF rPMS in Korean Patients With NSCLC
Boehringer Ingelheim
Afatinib Osimertinib Sequencing NIS
Boehringer Ingelheim
Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer
Genomic Health®, Inc.
LUME BioNIS: a Biomarker Study in Patients With NSCLC
Boehringer Ingelheim
Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology
Baptist Memorial Health Care Corporation
Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.
University of Liege
GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations
Boehringer Ingelheim
NIRVANA
Pfizer
Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
University of Kentucky
CacheMire
Chugai Pharma France
Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)
Pfizer
A Multi-Center Trial of the ProLung Testâ„¢
Fresh Medical Laboratories
Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)
University of Maryland, Baltimore
Real World Data on Gi(l)Otrif® Dose Adjustment
Boehringer Ingelheim
ALK NSCLC MENA
Pfizer